98 related articles for article (PubMed ID: 7517652)
1. Gene therapy and endothelial cell targeting for cancer.
Evans RR; Calmels TP; Pitt BR; Brookens MA; Johnson CS; Modzelewski RA; Lazo JS
Ann N Y Acad Sci; 1994 May; 716():257-64. PubMed ID: 7517652
[TBL] [Abstract][Full Text] [Related]
2. Phosphoinositide 3-kinase γ plays a critical role in bleomycin-induced pulmonary inflammation and fibrosis in mice.
Russo RC; Garcia CC; Barcelos LS; Rachid MA; Guabiraba R; Roffê E; Souza AL; Sousa LP; Mirolo M; Doni A; Cassali GD; Pinho V; Locati M; Teixeira MM
J Leukoc Biol; 2011 Feb; 89(2):269-82. PubMed ID: 21048214
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated human endostatin gene delivery demonstrates strain-specific antitumor activity and acute dose-dependent toxicity in mice.
Wen XY; Bai Y; Stewart AK
Hum Gene Ther; 2001 Mar; 12(4):347-58. PubMed ID: 11242527
[TBL] [Abstract][Full Text] [Related]
4. Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene.
Tran PL; Weinbach J; Opolon P; Linares-Cruz G; Reynes JP; Grégoire A; Kremer E; Durand H; Perricaudet M
J Clin Invest; 1997 Feb; 99(4):608-17. PubMed ID: 9045862
[TBL] [Abstract][Full Text] [Related]
5. Targeted gene transfer of hepatocyte growth factor to alveolar type II epithelial cells reduces lung fibrosis in rats.
Gazdhar A; Temuri A; Knudsen L; Gugger M; Schmid RA; Ochs M; Geiser T
Hum Gene Ther; 2013 Jan; 24(1):105-16. PubMed ID: 23134111
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between bleomycin-induced pulmonary fibrosis and vascular endothelial cell injury].
Wei JG; Cui GB; Wang W; Wei LX; Liang GM; Song LJ; Xu JK
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2004 Oct; 22(5):354-7. PubMed ID: 15555311
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of rat endothelial cell transforming growth factor-beta production by bleomycin.
Phan SH; Gharaee-Kermani M; Wolber F; Ryan US
J Clin Invest; 1991 Jan; 87(1):148-54. PubMed ID: 1702097
[TBL] [Abstract][Full Text] [Related]
8. Endothelial injury caused by antineoplastic agents.
Lazo JS
Biochem Pharmacol; 1986 Jun; 35(12):1919-23. PubMed ID: 2424454
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity to bleomycin-induced lung injury is not moderated by an antigen-limited T-cell repertoire.
Thatcher TH; Sime PJ; Barth RK
Exp Lung Res; 2005 Sep; 31(7):685-700. PubMed ID: 16203623
[TBL] [Abstract][Full Text] [Related]
10. Histopathological Correlations between Mediastinal Fat-Associated Lymphoid Clusters and the Development of Lung Inflammation and Fibrosis following Bleomycin Administration in Mice.
Elewa YHA; Ichii O; Takada K; Nakamura T; Masum MA; Kon Y
Front Immunol; 2018; 9():271. PubMed ID: 29497425
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor as a marker of tumor endothelium.
Brekken RA; Huang X; King SW; Thorpe PE
Cancer Res; 1998 May; 58(9):1952-9. PubMed ID: 9581838
[TBL] [Abstract][Full Text] [Related]
12. In vivo gene transfer of an extracellular domain of platelet-derived growth factor beta receptor by the HVJ-liposome method ameliorates bleomycin-induced pulmonary fibrosis.
Yoshida M; Sakuma-Mochizuki J; Abe K; Arai T; Mori M; Goya S; Matsuoka H; Hayashi S; Kaneda Y; Kishimoto T
Biochem Biophys Res Commun; 1999 Nov; 265(2):503-8. PubMed ID: 10558898
[TBL] [Abstract][Full Text] [Related]
13. A novel vascular endothelial growth factor heparin-binding domain substructure binds to glycosaminoglycans in vivo and localizes to tumor microvascular endothelium.
El-Sheikh A; Liu C; Huang H; Edgington TS
Cancer Res; 2002 Dec; 62(23):7118-23. PubMed ID: 12460934
[TBL] [Abstract][Full Text] [Related]
14. A specific antagonist of the p110delta catalytic component of phosphatidylinositol 3'-kinase, IC486068, enhances radiation-induced tumor vascular destruction.
Geng L; Tan J; Himmelfarb E; Schueneman A; Niermann K; Brousal J; Fu A; Cuneo K; Kesicki EA; Treiberg J; Hayflick JS; Hallahan DE
Cancer Res; 2004 Jul; 64(14):4893-9. PubMed ID: 15256460
[TBL] [Abstract][Full Text] [Related]
15. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
16. Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice.
Tabata C; Tabata R; Kadokawa Y; Hisamori S; Takahashi M; Mishima M; Nakano T; Kubo H
J Immunol; 2007 Jul; 179(1):708-14. PubMed ID: 17579094
[TBL] [Abstract][Full Text] [Related]
17. CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling.
Burdick MD; Murray LA; Keane MP; Xue YY; Zisman DA; Belperio JA; Strieter RM
Am J Respir Crit Care Med; 2005 Feb; 171(3):261-8. PubMed ID: 15502109
[TBL] [Abstract][Full Text] [Related]
18. Atrial natriuretic peptide protects against bleomycin-induced pulmonary fibrosis via vascular endothelial cells in mice : ANP for pulmonary fibrosis.
Okamoto A; Nojiri T; Konishi K; Tokudome T; Miura K; Hosoda H; Hino J; Miyazato M; Kyomoto Y; Asai K; Hirata K; Kangawa K
Respir Res; 2017 Jan; 18(1):1. PubMed ID: 28049526
[TBL] [Abstract][Full Text] [Related]
19. Prevention and treatment of bleomycin-induced pulmonary fibrosis with the lactate dehydrogenase inhibitor gossypol.
Judge JL; Nagel DJ; Owens KM; Rackow A; Phipps RP; Sime PJ; Kottmann RM
PLoS One; 2018; 13(5):e0197936. PubMed ID: 29795645
[TBL] [Abstract][Full Text] [Related]
20. ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.
Davis PD; Dougherty GJ; Blakey DC; Galbraith SM; Tozer GM; Holder AL; Naylor MA; Nolan J; Stratford MR; Chaplin DJ; Hill SA
Cancer Res; 2002 Dec; 62(24):7247-53. PubMed ID: 12499266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
